Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women
Binghe Xu, Huiping Li, Qingyuan Zhang, Wan Sun, Yanke Yu, Wei Li, Shusen Wang, Ning Liao, Peng Shen, Yuan Liu, Yaling Huang, Carlos Linn, Huadong Zhao, John Jiang, Diane Wang
Topics & Concepts
PalbociclibLetrozoleMedicinePharmacokineticsBreast cancerOncologyCancerBiomarkerInternal medicineTamoxifenMetastatic breast cancerBiologyBiochemistryAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysHER2/EGFR in Cancer Research